RZLT Overview
Upcoming Projects (RZLT)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (RZLT)
-
Revisiting RZ358 (ersodetug) in Congenital hyperinsulinism (CHI) ahead of the topline clinical trial readout
Ticker: RZLT
Executed On: Sep 26, 2025 at 04:00 PM EDT -
A Second Look: Discussing Congenital hyperinsulinism (CHI) and the potential of Rezolute's RZ358
Ticker: RZLT
Executed On: Aug 15, 2024 at 01:00 PM EDT -
Discussing the potential of Rezolute's RZ358 in treating Tumor hyperinsulinism
Ticker: RZLT
Executed On: Jul 25, 2024 at 05:00 PM EDT -
Discussing Congenital hyperinsulinism (CHI) and the potential of Rezolute's RZ358
Ticker: RZLT
Executed On: Jul 17, 2024 at 04:30 PM EDT -
Delving into the topline results from the Phase 2 clinical study of RZ402 in patients with Diabetic Macular Edema (DME)
Ticker: RZLT
Executed On: May 29, 2024 at 09:00 AM EDT -
Discussing the development landscape of treatments for Congenital Hyperinsulinism (CHI) specifically: CRN04777, RZ358, and Avexitide.
Tickers: CRNX, RZLT, EIGR
Executed On: Feb 22, 2022 at 11:00 AM EST
Upcoming & Overdue Catalysts (RZLT)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (RZLT)
Strategic Initiatives (RZLT)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
